Global Epinephrine Autoinjector Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through a prescription by doctors. Each prescription comes with two auto-injectors in a set.

Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
In the last several years, the development of Epinephrine Autoinjector industry is relative high with average production growth rate of 14.66%. In 2016, the global capacity of Epinephrine Autoinjector is nearly 8.35 million units and the actual production is about 6.8 million units.

North America, especially United States is the largest market of Epinephrine Autoinjector. In 2015, the North America Epinephrine Autoinjector still hold more than market share more than 93% in production market. On the other hand, North America also occupied 60% percent in the consumption volume market.

Though Europe and Asia Epinephrine Autoinjector industry is developing fast, the gap between production and consumption is still huge. So there are ten thousands of Epinephrine Autoinjector exporting from USA to Europe and Asia.

Corresponding with the fast growth of North America Epinephrine Autoinjector production, the price growth of Epinephrine Autoinjector is also huge. So the global Epinephrine Autoinjector production value market is also fast developing.

In 2020, the global Epinephrine Autoinjector market size was US$ 2161.2 million and is forecast to 3243.4 million US in 2027, growing at a CAGR of 7.0% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Epinephrine Autoinjector.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Epinephrine Autoinjector market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Epinephrine Autoinjector market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Epinephrine Autoinjector market. Readers of the report can become informed about current and future trends of the global Epinephrine Autoinjector market and how they will impact market growth during the forecast period.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Segment by Type
0.30 mg
0.15 mg

Segment by Application
Under 6 Years
6 to 12 Years
Over 12 Years

By Company
Mylan
Sanofi
ALK Abello
Impax